CoreWeave Securities Lawsuit Enters Lead‑Plaintiff Phase Ahead of March 13 Deadline

The suit claims the AI infrastructure firm understated single‑supplier data‑center delays that later preceded sharp share declines.

Overview

Investors who purchased CoreWeave shares between March 28 and December 15, 2025 have until March 13, 2026 to seek lead‑plaintiff appointment in Masaitis v. CoreWeave, Inc., pending in the U.S. District Court for the District of New Jersey.
The complaint alleges CoreWeave overstated its capacity to meet demand and minimized risks tied to dependence on a single third‑party data‑center developer.
Alleged corrective events include the October 30, 2025 termination of the Core Scientific merger, after which shares fell more than 6%, according to the filings.
On November 10–11, 2025, CoreWeave cut 2025 guidance citing a developer running behind schedule, and the CEO acknowledged the delays involved one provider, with shares sliding more than 16%.
A December 15, 2025 Wall Street Journal report described months‑long setbacks at a Denton, Texas cluster intended for OpenAI and other sites linked to Core Scientific, followed by an additional decline of about 3.4%.